Co-Diagnostics, Inc. (CODX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 1.1000 |
| Open | 1.1000 |
| Bid | 1.0600 x 100 |
| Ask | 1.1500 x 100 |
| Day's Range | 1.0900 - 1.1300 |
| 52 Week Range | 0.9750 - 1.8900 |
| Volume | |
| Avg. Volume | 58,666 |
| Market Cap | 34.406M |
| Beta (5Y Monthly) | -0.65 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2000 |
| Earnings Date | Aug 08, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.00 |
Simply Wall St.Co-Diagnostics First Quarter 2024 Earnings: Misses Expectations
Co-Diagnostics ( NASDAQ:CODX ) First Quarter 2024 Results Key Financial Results Net loss: US$9.31m (loss widened by 62...
Insider MonkeyCo-Diagnostics, Inc. (NASDAQ:CODX) Q1 2024 Earnings Call Transcript
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2024 Earnings Call Transcript May 9, 2024 Co-Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.31204 EPS, expectations were $-0.21. CODX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the […]
PR NewswireCo-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended March 31, 2024.
© 2024 Yahoo. All rights reserved.